• Avandia®
• Avandia® Death Risk
• Avandia® Heart Attack
• Avandia® Pph
• Congestive Heart Failure
• Dangers of Avandia®
• Avandia® Diabetes
• Avandia® Recall
• Avandia® Side Effects
• Avandia® Information
• Avandia® Attorneys
• Avandia® Lawyers
• Avandia® Lawsuit
• Avandia® Class Action Lawsuits
• Avandia® Litigations
• Avandia® Settlements
• Avandia® Overdose
• Avandia® & Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

The world’s top-selling diabetes drug—Avandia®—has been linked to PPH (primary pulmonary hypertension), an increased risk of heart failure, heart attack, and death. Patients who have taken Avandia® and been diagnosed with PPH or related condition may be able to hold the drug’s maker, GlaxoSmithKline, liable for damages in an Avandia® lawsuit. According to Food and Drug Administration documents, the pharmaceutical company was aware of Avandia®’s risks as early as 2000 but failed to warn patients and physicians.

Since its approval, Avandia® has been prescribed to more than 10 million Americans and millions more worldwide. If you are among the many who have taken Avandia® and suffered a severe side effect such as PPH, you should consult with an attorney as soon as possible to learn more about recovering your losses.

About PPH

PPH is a serious condition that may precede heart failure and is characterized by the narrowing of blood vessels and the onset of high blood pressure. Symptoms of PPH are typically subtle, sometimes causing a delay in diagnosis. Patients taking Avandia® who experience the following PPH symptoms should consult with a physician immediately:

• Shortness of breath
• Chest pain
• Extreme fatigue
• Ankle swelling
• Faintness
• Bluish tinting of the lips or skin

In severe cases, Avandia®-related PPH may require a heart-lung transplant or result in death.

Avandia® Black Box Warning

The FDA directed GlaxoSmithKline, the drug’s maker, to add a bold black box warning to Avandia®’s label in June 2007 to alert patients and physicians to the heightened risk of heart failure—the precursor of which is often PPH. The agency’s action came less than a month after the New England Journal of Medicine published a report linking Avandia® to a 30 to 40 percent increased risk of heart attack and heart-related death. The risk of heart failure, however, is considered a separate issue from the drug’s heart attack risks, which are still being evaluated.

Diagnosed with Avandia®-Related PPH?

Protect your legal rights by contacting our experienced Avandia® attorneys today. You may be entitled to compensation for your losses, including the cost of medical treatment, mental anguish, and pain and suffering, among other things.

"FDA Announces Avandia® Label Change"

The FDA announced that is has made a change regarding cardiovascular risks to the Avandia® (rosiglitazone) label and patient Medication Guide, Feb. 4, 2011.

The FDA announcement also said that Avandia®'s drug label was updated ...

» Read More

"Risk of Death Halts Government Study"

A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.

The 10,000 patient trial was examining the effectiveness of aggressive ...

» Read More

"Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avan"

A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.

Ob...

» Read More